Trevena to Host Analyst and Investor Day on October 28, 2015

October 21, 2015 07:00 AM Eastern Daylight Time

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company
focused on the discovery and development of biased ligands targeting G
protein coupled receptors (GPCRs), today announced that it will host an
Analyst and Investor Day on Wednesday, October 28, 2015 in New York
City. Presentations will begin at 12:00 p.m. Eastern Daylight Time and
will be streamed simultaneously as a webcast. The event is expected to
conclude by 3:00 p.m.

The presentations will focus on the Company’s clinical programs and will
feature members of the Trevena management team and leading experts in
acute heart failure and pain management, including:

G. Michael Felker, M.D., M.H.S., Professor of Medicine and Chief of
the Heart Failure Section at Duke University School of Medicine, and
Director of Heart Failure Research at the Duke Clinical Research
Institute;